Thursday, September 28, 2017-Digital Marketing Success for CRO’s

8am - 10am
Biocom- 10996 Torreyana Rd. Suite 200, San Diego, CA 92121
Download Presentation Download

Digital Marketing Success for CRO’s

An introduction to creating strategic, targeted, and measurable online campaigns
Today’s social and technology environment is turning traditional marketing for CROs on its head. Instead of telling the customer what to think, you need to find out what they already think and go from there, continually adjusting your approach based on real interactions with real customers every day. Digital marketing operates within its own paradigm requiring an adept use of analytical tools.

The evolution of digital marketing isn't really about the brands; it's about consumers exercising more control over their choices. This seminar demonstrates how using this single realization as a starting point helps you build and implement more effective campaigns.

Experienced marketing executives from Allurdata (a noted healthcare analytics company from Denver) and Mentus (San Diego’s most experienced biotech marketing firm) will provide insight on how to rapidly respond to change in consumer behavior with brand evolution and positioning with a digital marketing strategy.
Learn about Brand Staging utilizing your brand image and messaging. Determine the Data Model best suited to your objectives, and then tune it to the most effective consumer and business response.


Analytics Panelist – Allurdata – Bob Durham, President
Brand Panelist – Mentus – Guy Iannuzzi, President

Please register here:

October 11th, 2017- Concept to Commercial: A Clinical and Regulatory Outlook, 8am-10am

8am - 10am
Biocom McGraw Boardroom-10996 Torreyana Suite 200, San Diego, CA 92121

Biocom CRO Presents: Concept to Commercial: A Clinical and Regulatory Outlook

Imagine that you’re the CEO of a biotechnology company developing a pipeline of novel drugs. What do you do to prepare your team and your product to succeed in the clinic? Please join us as we hear from three industry veterans about the critical success factors for clinical development at three transition points: discovery to non-clinical development, non-clinical development to Phase 1 clinical studies, and Phase 1 to Phase 2 clinical studies.

Bob Gauthier, MS
Vice President, Product Development, Therapeutics, Inc.

Bob Gauthier is responsible for Product Development at Therapeutics, including all aspects of planning, managing, and executing product development, with an emphasis on leading cross-functional project teams to deliver novel products to the dermatology marketplace.

Louis Scotti
Vice President, Business Development, IriSys

Mr. Scotti joined IriSys in 2015 after previously serving on its Board of Directors from 2007 until 2012. He has headed business development, marketing, new products and investor/public relations functions during a long career in the bio/pharma industry both in the U.S. and internationally. His responsibilities at IriSys include business development, commercial planning and managing contracts with clients and partners.

Stan McDermott, PharmD, MS, RPh
Managing Director, Clinical Research, Cardinal Health
Dr. McDermott has managerial responsibilities for a team of clinical research consultants providing clinical strategy, operations and medical writing services. He is also a technical leader for clinical development programs. He has experience with regulatory strategies; clinical development planning, execution and reporting; clinical trial design, management and reporting and operational responsibilities.


Mark Hurtt, MD
Clinical Research and Translational Medicine Consultant

Dr. Hurtt provides hands-on assistance to companies preparing for Phase 1 and Phase 2 clinical trials and critical interactions with FDA and EMA.